Intraoperative MRI Guides Precision Treatment in Parkinson Disease Clinical Trial
FDA Approves Second Alzheimer Disease Infusion Therapy
ACR Releases Updated MR Safety Manual
Deep-Learning Improves Diagnosis, Management of Soft Tissue Sarcomas
Study Challenges ED Protocol for Repeat CTs for Geriatric Head Injuries and Blood Thinners
ACR Launches First Medical Practice AI QA Program
Gadopiclenol: Considerations for Use in Pediatric MRI
GE HealthCare to Create MRI Research Center With Cincinnati-Based Health Systems
Konica Minolta, Apollo Partner on Clinical Workflows, Image-Enabled EMR
Rady Children’s Launches No-Cost 3D Model Viewing Technology
Clinical Applications of Gadopiclenol in Body MRI
FujiFilm Nets FDA Clearance for Compact 128-Slice CT System
Removing Ovaries Before Menopause Associated With Reduced Brain White Matter Integrity
Philips Launches Zeniton 90 Motorized Mobile C-Arm
Early-Stage HCC Ablation Cost Lower Than Other Surgical Alternatives
Even Postmortem Diagnosis of Essential Tremor Helps Families Learn Risk
Advanced Brain Imaging Finds “Time Cells” Are Critical for Advanced Learning
Konica Minolta Healthcare, Christie Innomed Announce Partnership in Healthcare IT
Low-Count Quantitative SPECT Shows Promise for Personalizing Cancer Treatment
New Neuroimaging Analysis Approach Improves Cognition, Behavior Prediction
Study Reports Unfold AI Helps Physicians Identify Extent of Prostate Cancer With 84% Accuracy
Philips Launches Implantable Device to Treat Symptomatic Venous Outflow Obstruction
FDA Clears Avicenna.AI Solution for Detection of Vertebral Compression Fractures
UC-Davis-Built PET Scanner Can Visualize Blood Supply in Lung Cancer
SNMMI Announces 2024 Fellows and Awards, Votes in New Leadership
FAPI PET/CT Improves Staging of Newly Diagnosed Breast Cancer Compared to FDG
New Chelating Agent Lowers Toxicity in PSMA Radiopharmaceutical Therapy
Dual-Isotope Radionuclide Therapy Safe, Effective in Colorectal Cancer
Ultra-Low Dose PET Protocol Eliminates Need for CT
How to Time Your Cloud Transition: A Radiologist's Perspective
AI Tool Accurately Detects Six Different Cancer Types Using Whole-Body PET/CT
Canon, Hermes Combine Solutions in Sales Agreement
High-Quality Images of “Alzheimer Disease of the Heart” Captured by Novel Radiotracer
GE Healthcare Announces New Cyclotron, PET/CT Systems and AI-Based Reconstruction Technology at SNMMI 2024
PET/CT Superior to MRI for Lesion Detection in Head and Neck Paragangliomas
FAP-Targeted Therapy Shows Significant Efficacy Controlling Advanced Sarcomas
FAPI PET/CT Better Than FDG in Predicting Progressive Lung Disease
New Radiotracer Enables Same-Day Imaging of Gastrointestinal Cancer Biomarker, Identifies Targeted Therapy Candidates
Siemens Healthineers Launches High-Performance PET/CT at SNMMI 2024
Showing articles tagged with MRI
Gadopiclenol: Considerations for Use in Pediatric MRI
Clinical Applications of Gadopiclenol in Body MRI
Chemical Exchange Saturation Transfer for Epilepsy Imaging
By Brown JD, Kim H, Zhe Sun P, Hu R
At ECR 2024, Guerbet Set to Unveil AI Program, Bring New Contrast to EU
Researchers Use Macrophage-Adhering Gadolinium Micropatches to Visualize mTBIs
MagSense HER2 MR Imaging Agent Found Safe, Tolerable in Phase I Study
Nanosized Contrast Agents Could Enhance MR Imaging
Celebrating the First Clinical Administration of Elucirem™ (Gadopiclenol) Injection for MRI
Guerbet Showcases MR Agent Elucirem™ (Gadopiclenol) injection, Administered at Half the Dose of Gadolinium, and AI Suite
Bracco’s Commitment to Advancing the Future of Imaging Has No Boundaries
Radiological Detection of Cardiac Amyloid: MRI with Pathological Correlation
By Khurana NK, Jha S
Researchers Develop Single-Chain Nanoparticles That Could Serve as Contrast Agents
Alzheimer Disease Imaging in the Era of Anti-Amyloid Treatment
By Bash S, Tanenbaum LN
PROMISE Reinforces Safety, Efficacy of Gadopiclenol MRI Contrast
Copper in MRI Contrast Agents Could Create Clearer Images
Guerbet and Applied Radiology Launch Elucirem | The Reveal Image Challenge
ACR Classifies Bracco's VUEWAY as Group II Agent
ACR Committee Classifies Guerbet’s Elucirem a Group II Agent
GE HealthCare Launches New MRI Agent
First Patient Dosed With Newly Commercialized Elucirem MRI Contrast
MRI Contrast Innovation | A New High-Relaxivity, High Stability GBCA
Normative Left Ventricular Segmental T2 Mapping Values and Relationship With Cardiac Function in Cardiac Sarcoidosis Patients
By Chamberlin J, Kabakus IM, Kocher MR, Aquino G, Waltz J, Stringer N, Dennis DJ, Wortham A, Varga-Szemes A, Reiter W, James WE, Houston BA, Baruah D, Hardie AD, Burt JR
Guerbet Prepares for Launch of Elucirem (Gadopiclenol) injection, High-Relaxivity MRI Contrast Agent
The Promise of VUEWAY™ Gadopiclenol Injection
Neurological MRI: Trends in Contrast Utilization
Radiologists Concerned With Contrast Agent Availability as MRI Procedures Increase
Gadoxetate Disodium MRI Identifies Hepatocellular Adenomas
Fresenius Kabi Launches New Brain MRI Contrast
FDA Approves Bracco Diagnostics’ Gadopiclenol Injection, VUEWAY
US FDA Approves Guerbet’s Elucirem MRI Contrast
Contrast-Enhanced In-Phase Dixon Sequence for Detecting Breast Biopsy Clips
MR Contrast Produced by Adding Gadolinium Ions to Calcium Carbonate Prenucleation Clusters
The Use of Contrast-enhanced MRI in At-risk Patient Populations
By Tanenbaum LN, Roberts D
MRI Contrast Selection: Greater Stability or Higher Relaxivity?
Diffuse Leptomeningeal Glioneural Tumor
Clinical Trial of Gadolinium-Free MRI Contrast Starts
Langerhans Cell Histiocytosis | Case 2
FDA Recommends Thyroid Monitoring in Babies and Young Children Who Receive Iodine-Containing Contrast Media
FDA, EMA to Review Gadopiclenol
Reaction to CT Contrast Increases MRI Contrast Risk
Showing articles tagged with MRI
© Anderson Publishing, Ltd. 2024 All rights reserved. Reproduction in whole or part without express written permission Is strictly prohibited.